Table 1.
Comparison of the DAT, SERT, and NET-mediated Release Activity and 5-HT2A Receptor Activity of Substituted Tryptamines
| |||||||||
|---|---|---|---|---|---|---|---|---|---|
| EC50, (nM)a | 5-HT2Ab | ||||||||
| PAL | # | Substituent | R | R’ | DA | 5HT | NE | EC50, (nM) | EMAX, (%) |
| 287 | 1 | - | - | - | 12.6 ± 0.4c | 3.4 ± 0.2 c | 11.1 ± 0.9 c | - | - |
| 235 | 4a | - | H | H | 164 ± 16 | 32.6 ± 2.6 | 716 ± 46 | 7.36 ± 0.56 | 104 ± 4 |
| 152 | 4b | - | Me | H | 321 ± 23 | 22.4 ± 1.4 | 733 ± 94 | 50.7 ± 7.1 | 96 ± 2 |
| 536 | 4c | - | Et | H | 6660 ± 551d | 18.6 ± 1.6 | 3862 ± 635d | 38.3 ± 2.7 | 99 ± 2 |
| 637 | 4d | 1-Me | H | H | >10,000 | 53.1 ± 4.9 | >10,000 | 209 ± 40 | 99 ± 3 |
| 551 | 4e | 4-F | H | H | 106 ± 5 | 108 ± 9 | 1123 ± 211 | 28.1 ± 8.4 | 108 ± 3 |
| 548 | 4f | 4-OMe | H | H | >10,000 | 4114 ± 261d | >10,000 | 9.02 ± 0.65 | 108 ± 2 |
| 22 | 4g | 5-Me | H | H | >10,000 | 139 ± 19 | >10,000 | 6.00 ± 1.1 | 100 ± 2 |
| 441 | 4h | 5-Cl | H | H | 476 ± 34 | 19.1 ± 2.9 | >10,000 | 4.11 ± 0.59 | 109 ± 3 |
| 518 | 4i | 5-Br | H | H | 478 ± 25 | 75.0 ± 7.7 | >10,000 | 5.14 ± 0.90 | 108 ± 1 |
| 284 | 4j | 5-F | H | H | 82.3 ± 6.8 | 10.1 ± 0.9 | 464 ± 46 | 2.64 ± 0.36 | 110 ± 2 |
| 234 | 4k | 5-OMe | H | H | 11031 ± 580 | 2169 ± 259 | >10,000 | 0.503 ± 0.09 | 119 ± 2 |
| 227 | 41 | 6-F | H | H | 106 ± 4 | 4.4 ± 0.4 | 1575 ± 104 | 4.56 ± 0.28 | 101 ± 2 |
| 263 | 4m | 6-OMe | H | H | 113 ± 8 | 53.8 ± 5.4 | 465 ± 45 | 2443 ± 491 | 111 ± 5 |
| 522 | 4n | 6-Me | H | H | 353 ± 13 | 51.6 ± 5.8 | >10,000 | 75.3 ± 10 | 110 ± 4 |
| 286 | 4o | 7-Me | H | H | 3380 ± 220 | 23.7 ± 1.9 | >10,000 | 44.7 ± 5.7 | 103 ± 3 |
| 532 | 4p | 7-Cl | H | H | 1330 ± 61 | 8.03 ± 1.3 | 656 ± 60 | 18.8 ± 4.0 | 102 ± 2 |
| 533 | 4q | 7-OMe | H | H | 2118 ± 88 | 44.6 ± 3.8 | 5600 ± 815 | 496 ± 50 | 107 ± 3 |
| 17 | 7a | - | H | Me | 78.6 ± 4.0 | 21.7 ± 1.0 | 112 ± 6 | 23.1 ± 2.4 | 103 ± 3 |
| 542 | 7b | 5-Cl | H | Me | 54.3 ± 1.8 | 16.2 ± 2.2 | 3434 ± 516 | 6.27 ± 1.3 | 105 ± 1 |
| 212 | 7c | 5-F | H | Me | 37.0 ± 2 | 14 ± 1 | 78 ± 5 | 8.47 ± 1.9 | 107 ± 3 |
| 125 | 7d | - | H | Et | 232 ± 17 | 23.2 ± 1.7 | 640 ± 76e | >10,000 | 21 ± 11 |
| 640 | (-)-7d | - | H | (R)-Et | 654 ± 50 | 54.9 ± 7.8 | 3670 ± 1190e | Inactive at 10 μM | |
| 647 | (+)-7d | - | H | (S)-Et | 57.6 ± 3.1 | 34.7 ± 4.9 | 592 ± 97e | 1250 ± 310 | 61 ± 8 |
| 526 | 7e | 5-Cl | H | Et | 1838 ± 150d | 33.2 ± 3.6 | >10,000 | 249 ± 22 | 87 ± 1 |
| 545 | 7f | 5-F | H | Et | 150 ± 7 | 36.6 ± 3.2 | 5334 ± 970 | 246 ± 46 | 87 ± 3 |
Release EC50 values are reported as means ± SD and are the result of N=3 performed in triplicate.
Calcium mobilization EC50 and EMAX values are reported as means ± SEM and are the result of three independent experiments performed in duplicate.
Release data22
Value is IC50 for uptake inhibition in nM.
7d, (-)-7d, and (+)-7d were partial releasers of NE with Emax values of 78%, 75% and 71% respectively.